Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
0.6940
-0.0260 (-3.61%)
At close: Apr 1, 2025, 4:00 PM
0.6847
-0.0093 (-1.34%)
After-hours: Apr 1, 2025, 4:06 PM EDT
Spero Therapeutics Employees
Spero Therapeutics had 46 employees as of December 31, 2023. The number of employees increased by 11 or 31.43% compared to the previous year.
Employees
46
Change (1Y)
11
Growth (1Y)
31.43%
Revenue / Employee
$1,042,978
Profits / Employee
-$1,490,565
Market Cap
38.80M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SPRO News
- 4 days ago - Spero Therapeutics, Inc. (SPRO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Spero Therapeutics Announces Fourth Quarter and Full Year 2024 Operating Results and Provides a Business Update - GlobeNewsWire
- 14 days ago - Spero Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 27, 2025 - GlobeNewsWire
- 5 weeks ago - UPDATE – Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 5 weeks ago - Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Spero Therapeutics: Undervalued Based On Just Tebipenem And GSK Deal - Seeking Alpha
- 2 months ago - Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes - GlobeNewsWire
- 4 months ago - Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update - GlobeNewsWire